Akèy › Anplwayè › Ascendis Pharma, Inc.
Ascendis Pharma, Inc.: Salè H-1B ak pajon
Ascendis Pharma, Inc. depoze 8 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 8. Medyèn salè yo ofri a: $218,160.
Èske Ascendis Pharma, Inc. pajone visa H-1B?
Ascendis Pharma, Inc. depoze 8 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Dec 19, 2025. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Demands Green Card (PERM) pou Ascendis Pharma, Inc.: 5 →
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Associate Director, Medical Safety Science | 2 | $225,000 |
| Director, Global PV Operations | 1 | $255,000 |
| IT Business Analyst | 1 | $150,000 |
| Scientist, Formulation Development | 1 | $135,000 |
| Head, Global PV Operations | 1 | $275,600 |
| Associate Director, Global PV Operations | 1 | $216,320 |
| Sr. Specialist, IT Business Analysis | 1 | $175,141 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 6 | $225,000 |
| FY2024 | 1 | $216,320 |
| FY2026 | 1 | $175,141 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Medical Scientists, Except Epidemiologists4
- Computer Systems Analysts2
- Regulatory Affairs Managers1
- Regulatory Affairs Specialists1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Sr. Specialist, IT Business Analysis | $175,141 Nivo III | Palo Alto, CA | Dec 19, 2025 | Jan 23, 2026 | Certifye |
| Associate Director, Global PV Operations | $216,320 Nivo IV | Palo Alto, CA | Jul 12, 2024 | Nov 29, 2024 | Certifye |
| Head, Global PV Operations | $275,600 Nivo IV | Palo Alto, CA | Aug 18, 2023 | Dec 15, 2023 | Certifye |
| Associate Director, Medical Safety Science | $220,000 Nivo IV | Palo Alto, CA | May 17, 2023 | Jun 12, 2023 | Certifye |
| Scientist, Formulation Development | $135,000 Nivo II | Redwood City, CA | Apr 26, 2023 | Oct 1, 2023 | Certifye |
| Associate Director, Medical Safety Science | $230,000 Nivo IV | Dublin, CA | Feb 16, 2023 | Mar 20, 2023 | Certifye |
| Director, Global PV Operations | $255,000 Nivo IV | Benicia, CA | Feb 14, 2023 | Feb 21, 2023 | Certifye |
| IT Business Analyst | $150,000 Nivo III | Palo Alto, CA | Jan 20, 2023 | Jan 23, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).